PatternsRadar
Sign in

SENORESSenores Pharmaceuticals Limited

NSE
1,090.80INR-22.10 (-1.99%)Close · 20 Nov 2026
16 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹5,024 CrMarket cap
36.3P/E (TTM)
52.6%Delivery

Filings & corporate actions

10 results filed
CSV
Next results · Q3 FY27
Expected 20 Jan 2027 – 18 Feb 2027
Estimate: filed 20–49 days after quarter end, last 8 times
2026
  • 16 NovresultsResults · Q2 FY27 · standalone-0.8%NSE
  • 29 OctresultsResults · Q2 FY27 · consolidated and standalone-7.0%NSE
  • 16 OctshareholdingShareholding · 30 Sept 2026+4.7%NSE
  • 27 JulresultsResults · Q1 FY27 · consolidated and standalone-6.2%NSE
  • 20 JulshareholdingShareholding · 30 Jun 2026-1.4%NSE
  • 27 MayresultsResults · Q4 FY26 · consolidated+0.7%NSE
  • 14 MayresultsResults · Q4 FY26 · consolidated and standalone+10.0%NSE
  • 7 AprshareholdingShareholding · 31 Mar 2026-0.8%NSE
  • 20 JanresultsResults · Q3 FY26 · consolidated and standalone+6.4%NSE
  • 12 JanshareholdingShareholding · 31 Dec 2025+0.3%NSE

Reaction to results · all yearsrose on day 0 in 5 of 8 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2729 Oct 2026-7.0%-4.8%—8.8×
Q1 FY2727 Jul 2026-6.2%-3.6%+4.8%4.1×
Q4 FY2614 May 2026+10.0%+16.4%+34.4%3.6×
Q3 FY2620 Jan 2026+6.4%-0.7%+4.8%3.3×
Q2 FY266 Nov 2025+2.2%-3.0%-3.5%2.6×
Q1 FY2624 Jul 2025-1.5%-2.0%+5.7%2.2×
Q4 FY2519 May 2025+3.5%+1.7%+12.3%1.2×
Q3 FY2524 Jan 2025+3.4%+1.4%-1.5%—
Average+1.4%+0.7%+8.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+18.9%
Profit YoY+22.0%
Interest cost YoY+31.0%
Revenue QoQ+6.7%
Profit QoQ+28.6%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

Open1,112.90
Day range1,084.60 – 1,123.90
52-week range706.00 – 1,599.00
From 52w high-31.8%
RSI (14)36.6
ATR (14)54.98
Volume2.10L
Avg volume (20D)3.85L
Rel volume0.54×
Volatility (1Y)43.1%
Turnover₹23.2Cr
Traded value (NSE)₹23.2Cr
VWAP1,103.77
SMA 50 / 2001,280.16 / 1,140.14
Price band20%

Delivery percentage

Latest · 20 Nov 202652.6%
20-day avg43.9%
1-year avg45.7%
Percentile (own history)86th
Range13.5–75.7%
Sessions471

Over the last 20 sessions SENORES settled 43.9% of its traded quantity, which is ordinary for an NSE equity. That is in line with its own one-year average of 45.7%. The latest session ranks higher than 86% of the 471 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders42.6K · +16.8% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy479 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.99%-7.13%-9.30%-27.92%-1.67%+39.77%

Valuation

Market cap₹5,024 Cr
Market cap (NSE)₹5,024 Cr
Free-float cap₹2,722 Cr
P/E (TTM)36.3
P/E (NSE)37.3
EPS (TTM)30.08
P/B5.0
Net margin (TTM)19.2%
Other income / PBT18.5%
ROE15.2%
Debt / equity0.38
Shares outstanding4.61Cr
Listed30 Dec 2024

Ownership

Promoter45.82%
Promoter Δ QoQ0.00 pp
Public54.18%
FII6.01%
DII10.84%
Pledged2.81%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)174.6175.2180.2192.3
YoY chg+69.4%+53.4%+30.6%+18.9%
Net profit (₹ Cr)33.636.730.536.6
YoY chg+104.4%+104.1%+43.8%+21.5%
Net margin19.2%20.9%16.9%19.0%
EPS7.297.966.608.82

Shareholding over time

By quarter

30 Sept 2026 · promoter 45.82% · public 54.18%
26 Dec 2024: promoter 45.76%31 Dec 2024: promoter 45.76%31 Mar 2025: promoter 45.77%30 Jun 2025: promoter 45.78%30 Sept 2025: promoter 45.80%31 Dec 2025: promoter 45.80%31 Mar 2026: promoter 45.82%30 Jun 2026: promoter 45.82%30 Sept 2026: promoter 45.82%
2024-122026-09
  • Promoter
  • Public and others
Promoter
45.82%
Public
54.18%
Promoter change
0.00 pp
Filed
16 Oct 2026
FII
6.01%
DII
10.84%
Promoter pledged
2.81%

Who the public is

Mutual funds
7.36%

+0.80 pp QoQ

Insurance
1.28%

-0.34 pp QoQ

FPI
6.01%

-0.61 pp QoQ

Retail ≤ ₹2L
16.21%

+0.74 pp QoQ

HNI > ₹2L
13.18%

-0.59 pp QoQ

NRI
0.81%

-0.07 pp QoQ

Bodies corporate
4.52%

+0.37 pp QoQ

Shareholders
42,642

+16.8% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Swapnil Jatin ShahPromoter · Individual7.72%
Ashokbhai Vijaysinh BarotPromoter · Individual7.55%
Remus Pharmaceuticals LimitedPromoter · Corporate7.08%
Renosen Pharmaceuticals Private LimitedPromoter · Corporate5.90%
Anar Swapnil ShahPromoter · Individual4.98%
Aviraj Overseas LLCPromoter · Corporate4.12%
HSBC MUTUAL FUND - HSBC MULTI CAP FUNDMutual fund2.87%
Sangeeta Mukur BarotPromoter · Individual2.26%
MANOJ PRAKASH SANGHVIIndividual1.86%
RATNAMANI MARKETING PRIVATE LIMITEDCorporate1.82%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
11 months ago
Disclosures on record
83
78 open-market of the newest 83
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
2 Mar 2026Dhruvalben Vishal ShahOtherBuy350₹2.7L777.95650 → 1.0K0.00%0.00 pp7(2)told 26 Feb 2026
1 Jan 2026Renosen Pharmaceuticals Private LimitedPromoterBuy6.0K₹49.4L822.6827.13L → 27.19L5.90%+0.01 pp7(2)told 1 Jan 2026
18 Dec 2025Renosen Pharmaceuticals Private LimitedPromoterBuy4.0K₹32.2L803.9227.09L → 27.13L5.89%+0.01 pp7(2)told 18 Dec 2025
16 Dec 2025Dhruvalben Vishal ShahOtherBuy150₹1.1L761.50400 → 5500.00%0.00 pp7(2)told 15 Dec 2025
12 Dec 2025Vinodkumar Gandalal ShahOtherBuy300₹2.3L782.961.4K → 1.6K0.00%0.00 pp7(2)told 12 Dec 2025
12 Dec 2025Vinodkumar Gandalal ShahOtherBuy100₹78,314783.141.3K → 1.4K0.00%0.00 pp7(2)told 12 Dec 2025
18 Nov 2025Pratik Sureshkumar ThakkarEmployeeBuy200₹1.6L781.873.3K → 3.5K0.01%+0.00 pp7(2)told 17 Nov 2025
15 Sept 2025Pratik Sureshkumar Thakkar HUFOtherBuy350₹2.4L688.26400 → 7500.00%0.00 pp7(2)told 13 Sept 2025
12 Sept 2025Chetan Bipinchandra ShahDirectorBuy500₹3.6L713.494.0K → 4.5K0.01%+0.00 pp7(2)told 12 Sept 2025
29 Aug 2025Ashokbhai Vijaysinh BarotPromoterBuy1.0K₹7.1L708.1834.44L → 34.45L7.48%+0.00 pp7(2)told 29 Aug 2025
28 Aug 2025Renosen Pharmaceuticals Private LimitedPromoterBuy2.5K₹17.5L698.1327.06L → 27.09L5.88%+0.01 pp7(2)told 28 Aug 2025
22 Aug 2025Ashokbhai Vijaysinh BarotPromoterBuy16.1K₹1.2Cr729.2534.28L → 34.44L7.48%+0.03 pp7(2)told 22 Aug 2025
22 Aug 2025Renosen Pharmaceuticals Private LimitedPromoterBuy1.0K₹7.0L698.9027.05L → 27.06L5.88%+0.00 pp7(2)told 22 Aug 2025
22 Aug 2025Dhananjay Ashokkumar BarotPromoterSell5.1K₹36.0L704.003.18L → 3.13L0.68%-0.01 pp7(2)told 22 Aug 2025
22 Aug 2025Dhananjay Ashokkumar BarotPromoterSell7.1K₹49.8L701.003.25L → 3.18L0.69%-0.02 pp7(2)told 22 Aug 2025
22 Aug 2025Dhananjay Ashokkumar BarotPromoterSell5.1K₹35.2L690.003.30L → 3.25L0.71%-0.01 pp7(2)told 22 Aug 2025
1 Aug 2025Amee Chetan ShahRelativeBuy300₹2.0L654.03200 → 5000.00%0.00 pp7(2)told 31 Jul 2025
29 Jul 2025Renosen Pharmaceuticals Private LimitedPromoterBuy3.0K₹19.4L645.1627.02L → 27.05L5.87%+0.01 pp7(2)told 28 Jul 2025
29 Jul 2025Chetan Bipinchandra ShahDirectorBuy500₹3.3L663.043.5K → 4.0K0.01%+0.00 pp7(2)told 29 Jul 2025
28 May 2025Renosen Pharmaceuticals Private LimitedPromoterBuy4.0K₹20.2L505.0026.98L → 27.02L5.87%+0.01 pp7(2)told 28 May 2025
13 Mar 2025Chetan Bipinchandra ShahDirectorBuy550₹3.1L564.393.0K → 3.5K0.01%+0.00 pp7(2)told 13 Mar 2025
27 Feb 2025Chetan Bipinchandra ShahDirectorBuy1.0K₹5.6L561.832.0K → 3.0K0.00%0.00 pp7(2)told 27 Feb 2025
27 Feb 2025Chetan Bipinchandra ShahDirectorBuy1.0K₹5.5L552.361.0K → 2.0K0.00%0.00 pp7(2)told 27 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy16₹8,359522.44984 → 1.0K0.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy142₹74,181522.40842 → 9840.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy23₹12,014522.35819 → 8420.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy46₹24,025522.28773 → 8190.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy76₹39,691522.25697 → 7730.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy37₹19,321522.19660 → 6970.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy95₹49,604522.15565 → 6600.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy23₹12,008522.09542 → 5650.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy20₹10,441522.05522 → 5420.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy298₹1.6L521.95224 → 5220.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy10₹5,218521.80214 → 2240.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy29₹15,132521.79185 → 2140.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy1₹521521.00184 → 1850.00%0.00 pp7(2)told 21 Feb 2025
21 Feb 2025Chetan Bipinchandra ShahDirectorBuy34₹17,736521.65150 → 1840.00%0.00 pp7(2)told 21 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy82₹43,378529.001.9K → 2.0K0.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy61₹32,253528.741.9K → 1.9K0.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy27₹14,277528.781.8K → 1.9K0.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy4₹2,115528.751.8K → 1.8K0.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy63₹33,320528.891.8K → 1.8K0.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy289₹1.5L528.951.5K → 1.8K0.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy922₹4.9L529.00552 → 1.5K0.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy1₹528528.00551 → 5520.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy124₹65,596529.00427 → 5510.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy4₹2,109527.25423 → 4270.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy270₹1.4L527.50153 → 4230.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy30₹15,823527.43123 → 1530.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy73₹38,500527.4050 → 1230.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy18₹9,492527.3332 → 500.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy16₹8,437527.3116 → 320.00%0.00 pp7(2)told 14 Feb 2025
17 Feb 2025Jeshika Hiten ParikhOtherBuy16₹8,440527.50— → 160.00%7(2)told 14 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy130₹71,825552.502.9K → 3.0K0.01%+0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy149₹82,233551.902.7K → 2.9K0.01%+0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy368₹2.0L551.952.4K → 2.7K0.01%+0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy23₹12,696552.002.3K → 2.4K0.01%+0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy45₹24,842552.042.3K → 2.3K0.01%+0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy61₹33,681552.152.2K → 2.3K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy65₹35,893552.202.2K → 2.2K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy82₹45,284552.242.1K → 2.2K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy180₹99,414552.301.9K → 2.1K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy38₹20,989552.341.9K → 1.9K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy10₹5,524552.401.8K → 1.9K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy398₹2.2L552.451.5K → 1.8K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy317₹1.8L552.501.1K → 1.5K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy1₹551551.001.1K → 1.1K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy454₹2.5L552.50679 → 1.1K0.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy3₹1,628542.67676 → 6790.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy1₹542542.00675 → 6760.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy18₹9,770542.78657 → 6750.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy527₹2.9L543.00130 → 6570.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy32₹17,372542.8840 → 720.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy38₹20,628542.842 → 400.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy1₹542542.001 → 20.00%0.00 pp7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy1₹542542.00— → 10.00%7(2)told 13 Feb 2025
14 Feb 2025Sanjay Shaileshbhai MajmudarDirectorBuy58₹31,491542.9572 → 1300.00%0.00 pp7(2)told 13 Feb 2025
28 Jan 2025Renosen Pharmaceuticals Private LimitedPromoterBuy4.0K₹20.2L504.4426.94L → 26.98L5.86%+0.01 pp7(2)told 28 Jan 2025

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 24 Dec 2025

CSV
12 of 40 deals
By year
DateDealClientQuantityPriceValue
24 Dec 2025Sell · bulkASTORNE CAPITAL VCC ARVEN5.00L792.12₹39.6Cr
29 Jul 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP3.16L689.98₹21.8Cr
29 Jul 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP3.16L689.33₹21.8Cr
29 Jul 2025Buy · bulkHRTI PRIVATE LIMITED2.69L686.66₹18.5Cr
29 Jul 2025Sell · bulkHRTI PRIVATE LIMITED2.37L688.87₹16.3Cr
24 Jul 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.39L685.44₹43.8Cr
24 Jul 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP6.39L684.96₹43.8Cr
24 Jul 2025Sell · bulkQE SECURITIES LLP2.48L684.18₹17.0Cr
24 Jul 2025Buy · bulkQE SECURITIES LLP2.44L686.01₹16.8Cr
19 Mar 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP2.38L635.98₹15.1Cr
19 Mar 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP2.38L634.95₹15.1Cr
6 Feb 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP3.12L609.00₹19.0Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to SENORES.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations103.0114.2138.0161.8174.6175.2180.2192.3
Other income5.211.83.45.43.817.72.88.9
Total income108.2126.0141.4167.2178.3192.9183.0201.3
Total expenses87.7105.3114.9126.5133.7145.5143.6153.7
└ Finance costs6.25.35.06.25.38.57.28.8
└ Depreciation4.25.26.08.17.99.39.910.3
Profit before tax20.520.726.540.644.647.439.547.6
Tax expense4.12.75.310.511.010.79.011.0
Net profit16.418.021.230.133.636.730.536.6
EPS5.043.814.606.547.297.966.618.85
Net margin15.95%15.73%15.35%18.62%19.24%20.93%16.90%19.03%
PBT margin19.88%18.11%19.20%25.12%25.55%27.06%21.90%24.74%
Tax rate19.79%13.10%20.05%25.89%24.71%22.64%22.83%23.08%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 29 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY25H1 FY26FY26H1 FY27
Total assets1,226.91,288.21,603.81,680.6
Current assets722.4663.8812.4766.3
└ Cash & equivalents105.486.045.618.0
└ Other bank balances280.1116.6114.182.7
└ Current investments0.00.00.00.0
└ Trade receivables123.9199.5324.8253.2
└ Inventories56.662.689.397.6
Total equity812.2834.4964.51,031.5
└ Attributable to owners786.2814.0933.61,003.0
└ Non-controlling interest26.120.430.928.6
└ Share capital46.146.146.146.1
Borrowings304.8231.8327.1394.5
└ Current142.379.1132.2181.6
└ Non-current162.5152.7194.9212.9
Trade payables67.2123.8234.7151.1
Current liabilities240.7277.7424.0411.6
Total liabilities414.6453.7639.3649.1
Net debt(80.7)29.2167.5293.8
Debt / equity0.380.280.340.38
Current ratio3.002.391.921.86

Cash flow, year to date

 FY25H1 FY26FY26H1 FY27
Operating cash flow(45.9)24.262.129.2
└ Capex(157.5)(96.7)(240.1)(136.6)
Free cash flow(203.4)(72.5)(178.1)(107.4)
Investing cash flow(429.5)41.3(120.6)(112.2)
Financing cash flow573.1(84.9)(1.3)55.4
└ Dividends paid0.00.00.00.0
└ Buybacks0.00.00.00.0
Net change in cash97.7(19.4)(59.8)(27.6)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SENORES at a glance

  • SENORES closed at ₹1,090.8 on 20 Nov 2026, -1.99% on the day, +39.8% over one year, 31.8% below its 52-week high of ₹1,599.
  • Delivery was 52.6% of traded quantity on 20 Nov 2026, the 86th percentile of its own 471 sessions with a reading (20-session average 43.9%, 1-year average 45.7%).
  • Market capitalisation is ₹5,024 crore at a trailing P/E of 36.3 (trailing EPS ₹30.08).
  • Q2 FY27 results (consolidated, filed 29 Oct 2026): revenue ₹192 crore (+18.9% year on year), net profit ₹37 crore (+21.5%); the price moved -7.0% on the first session after.
  • Promoters held 45.82% at 30 Sept 2026, unchanged on the previous filing, with 2.81% of promoter shares pledged.
  • Q3 FY27 results are expected between 20 Jan 2027 and 18 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE0RB801010
SeriesEQ
Listed30 Dec 2024
IPO price391.00 · band Rs.372 to Rs.391
IPO listing30 Dec 2024
NSE market cap · 17 Nov 2026₹5,244 Cr
Free-float market cap (NSE)₹2,540 Cr
Shares outstanding (NSE)4.61Cr
History from30 Dec 2024
Sessions471
Turnover rank#467

Sector history

  1. to 5 Oct 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
  2. from 5 Oct 2026Index industry · Healthcare

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.